Expand CDNA Menu
CDNA MENU

CDNA Latest Press Releases

-- July 31, 2026 --

CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire 6:45 PM

-- July 30, 2026 --

CareDx Announces Second Quarter 2026 Financial Results Business Wire 4:01 PM

-- July 16, 2026 --

CareDx to Report Second Quarter 2026 Financial Results on July 30, 2026 Business Wire 8:35 AM
CareDx Announces Finalization of Solid Organ Transplant Molecular Testing Local Coverage Determination Business Wire 8:30 AM

-- July 1, 2026 --

CareDx Completes Acquisition of Naveris, Extending Leadership into High-Growth Specialty Oncology Business Wire 4:05 PM

-- June 30, 2026 --

CareDx Announces Completion of Sale of Lab Products Business to Eurobio Scientific Business Wire 4:05 PM

-- June 18, 2026 --

CareDx Precision Medicine Diagnostics Showcased in Over 30 Abstracts and 9 Oral Presentations at the 2026 American Transplant Congress Business Wire 7:05 AM

-- June 16, 2026 --

CareDx Announces Second KOAR Analysis Published in the Journal of the American Society of Nephrology Business Wire 4:05 PM

-- May 20, 2026 --

CareDx to Participate in Upcoming Investor Conferences Business Wire 4:01 PM

-- May 11, 2026 --

CareDx Announces Dismissal of 2021 Qui Tam Suit Business Wire 4:05 PM

-- May 1, 2026 --

CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire 4:01 PM

-- April 28, 2026 --

CareDx Announces Agreement to Acquire Naveris, A Leader in Viral-Mediated Cancer MRD Surveillance Testing Business Wire 4:05 PM
CareDx Announces First Quarter 2026 Financial Results Business Wire 4:01 PM

-- April 21, 2026 --

CareDx Announces Presentation of More Than 50 Abstracts Including 16 Oral Presentations at the International Society for Heart and Lung Transplantation's 46th Annual Meeting Business Wire 4:01 PM

-- April 20, 2026 --

CareDx Introduces AlloSeq Nano at EFI 2026, Expanding HLA Typing Portfolio with Long-Read Sequencing Business Wire 7:05 AM

-- April 15, 2026 --

CareDx Announces Agreement to Divest Lab Products Business to EuroBio Scientific for $170 Million and Announces First Quarter Preliminary Financial Results Business Wire 4:30 PM

-- April 14, 2026 --

CareDx to Report First Quarter 2026 Financial Results on April 28, 2026 Business Wire 4:01 PM
Market Data Delayed 15 Minutes